Respirology

Canadian Thoracic Society issues guidance for managing patients with asthma and COPD during salbutamol inhaler shortage

Researchers from across Canada will collaborate on a vast clinical trial to study whether the plasma of recovered patients can be used to treat COVID-19.

Chloroquine, hydroxychloroquine and azithromycin are being used to treat and prevent COVID-19 despite weak evidence for effectiveness, and physicians and patients should be aware of the drugs’ potentially serious adverse events.

Thousands of scientists around the world are working on problems raised by the COVID-19 pandemic. Here is a summary of some recent research from peer-reviewed academic journals and scientific agencies...

Plan focuses on eight elements – stuff, staff, space, systems, sedation, separation, communication and equity

Randomized controlled trials are the only way to find effective and safe treatments for COVID-19

Now equal number of Canadians who have tested positive for COVID-19 contracted the virus from travel and from transmission within their own communities

Pharmacy and medical organizations issue statements to discourage off-label prescribing